Yuanming Zhang

机构：Xinjiang Medical University, Tumor Hospital of Xinjiang Medical University

发表论文 5 篇 · 总被引 38 次 · h-index 1

代表论文

• M2-type tumor-associated macrophages upregulated PD-L1 expression in cervical cancer via the PI3K/AKT pathway (2024 · European journal of medical research · 被引 37)
• Myd88 and Sqstm1 as novel biomarkers for pyroptosis-driven immune checkpoint inhibitors-related myocarditis (2026 · International Immunopharmacology · 被引 1)
• Bioinformatics and network pharmacology to explore Huangqi Guizhi Wuwu Decoction in regulating mitophagy to ameliorate doxorubicin-induced cardiotoxicity the potential mechanism (2026 · Medicine)
• Combined Nivolumab and Ipilimumab Therapy Promotes Immune‐Mediated Cardiomyocyte Apoptosis Through TLR4–Myd88–NF‐ Κ b–Driven Activation of the NLRP3 Inflammasome (2026 · Human Mutation)
• Dexmedetomidine Regulates HMGB1 Transferred by HK-2 Cell-Derived Exosomes to Suppress Myocardial Cell Pyroptosis by Activating the TLR4 Signaling Pathway. (2025 · PubMed)